Ppp5ctm1a(EUCOMM)Wtsi
|
WTSI
|
Fasted Clinical Chemistry / Glycerol
|
HOM
|
9f:8m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.00992
|
Successful |
Ppp5ctm1a(EUCOMM)Wtsi
|
WTSI
|
Fasted Clinical Chemistry / LDL-cholesterol
|
HOM
|
9f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.0625
|
Successful |
Ppp5ctm1a(EUCOMM)Wtsi
|
WTSI
|
Fasted Clinical Chemistry / HDL-cholesterol
|
HOM
|
9f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.178
|
Successful |
Ppp5ctm1a(EUCOMM)Wtsi
|
WTSI
|
Fasted Clinical Chemistry / Free fatty acids
|
HOM
|
9f:8m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.00144
|
Successful |
Ppp5ctm1a(EUCOMM)Wtsi
|
WTSI
|
Fasted Clinical Chemistry / Triglycerides
|
HOM
|
9f:8m
|
Linear Mixed Model framework, LME, including Weight
|
1.15×10-11
|
Successful |
Ppp5ctm1a(EUCOMM)Wtsi
|
WTSI
|
Fasted Clinical Chemistry / Total cholesterol
|
HOM
|
9f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.135
|
Successful |
Ppp5ctm1a(EUCOMM)Wtsi
|
WTSI
|
Fasted Clinical Chemistry / Glucose
|
HOM
|
9f:8m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
8.76×10-08
|
Successful |
Ppp5ctm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Glucose
|
HOM
|
8f:6m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.0841
|
Successful |
Ppp5ctm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Urea
|
HOM
|
8f:6m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.662
|
Successful |
Ppp5ctm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Creatinine
|
HOM
|
8f:6m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.917
|
Successful |
Ppp5ctm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Sodium
|
HOM
|
8f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.547
|
Successful |
Ppp5ctm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Potassium
|
HOM
|
8f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.322
|
Successful |
Ppp5ctm1a(EUCOMM)Wtsi
|
WTSI
|
Indirect Calorimetry / Heat Production (Metabolic Rate)
|
HOM
|
284f:310m
|
|
|
NotProcessed |
Ppp5ctm1a(EUCOMM)Wtsi
|
WTSI
|
Indirect Calorimetry / Oxygen consumption
|
HOM
|
284f:310m
|
|
|
NotProcessed |
Ppp5ctm1a(EUCOMM)Wtsi
|
WTSI
|
IPGTT / Blood glucose concentration
|
HOM
|
20f:m
|
|
|
NotProcessed |
Ppp5ctm1a(EUCOMM)Wtsi
|
WTSI
|
IPGTT / Blood glucose concentration
|
HOM
|
15f:35m
|
|
|
NotProcessed |
Ppp5ctm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Chloride
|
HOM
|
3f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.0546
|
Successful |
Ppp5ctm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Chloride
|
HOM
|
4f:m
|
Linear Mixed Model framework, LME, including Weight
|
0.204
|
Successful |
Ppp5ctm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Potassium
|
HOM
|
4f:m
|
Linear Mixed Model framework, LME, including Weight
|
0.858
|
Successful |
Ppp5ctm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Potassium
|
HOM
|
3f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.863
|
Successful |
Ppp5ctm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Sodium
|
HOM
|
3f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0660
|
Successful |
Ppp5ctm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Sodium
|
HOM
|
4f:m
|
Linear Mixed Model framework, LME, not including Weight
|
0.837
|
Successful |
Ppp5ctm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Creatinine
|
HOM
|
4f:m
|
Linear Mixed Model framework, LME, not including Weight
|
0.00327
|
Successful |
Ppp5ctm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Creatinine
|
HOM
|
3f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0445
|
Successful |
Ppp5ctm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Urea
|
HOM
|
4f:m
|
Linear Mixed Model framework, LME, including Weight
|
0.426
|
Successful |
Ppp5ctm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Urea
|
HOM
|
3f:7m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.458
|
Successful |
Ppp5ctm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Glucose
|
HOM
|
3f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.00341
|
Successful |
Ppp5ctm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Glucose
|
HOM
|
4f:m
|
Linear Mixed Model framework, LME, including Weight
|
0.538
|
Successful |
Ppp5ctm1a(EUCOMM)Wtsi
|
WTSI
|
DEXA / Fat/Body weight
|
HOM
|
9f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
8.18×10-05
|
Successful |
Ppp5ctm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Calcium
|
HOM
|
3f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.00113
|
Successful |
Ppp5ctm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Calcium
|
HOM
|
4f:m
|
Linear Mixed Model framework, LME, including Weight
|
0.0847
|
Successful |
Ppp5ctm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Albumin
|
HOM
|
4f:m
|
Linear Mixed Model framework, LME, including Weight
|
0.550
|
Successful |
Ppp5ctm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Albumin
|
HOM
|
3f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.937
|
Successful |
Ppp5ctm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Total protein
|
HOM
|
4f:m
|
Linear Mixed Model framework, LME, including Weight
|
0.242
|
Successful |
Ppp5ctm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Total protein
|
HOM
|
3f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.842
|
Successful |
Ppp5ctm1a(EUCOMM)Wtsi
|
WTSI
|
DEXA / Fat mass
|
HOM
|
9f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
5.12×10-05
|
Successful |
Ppp5ctm1a(EUCOMM)Wtsi
|
WTSI
|
Calorimetry / Carbon dioxide production
|
HOM
|
114f:307m
|
|
|
NotProcessed |
Ppp5ctm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Total cholesterol
|
HOM
|
8f:6m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.00349
|
Successful |
Ppp5ctm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Creatine kinase
|
HOM
|
4f:m
|
Linear Mixed Model framework, LME, including Weight
|
0.214
|
Successful |
Ppp5ctm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Creatine kinase
|
HOM
|
3f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.601
|
Successful |
Ppp5ctm1a(EUCOMM)Wtsi
|
WTSI
|
Calorimetry / Oxygen consumption
|
HOM
|
114f:307m
|
|
|
NotProcessed |
Ppp5ctm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Triglyceride
|
HOM
|
8f:6m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.183
|
Successful |
Ppp5ctm1a(EUCOMM)Wtsi
|
WTSI
|
Calorimetry / Heat production (metabolic rate)
|
HOM
|
114f:307m
|
|
|
NotProcessed |
Ppp5ctm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Free fatty acid
|
HOM
|
8f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0353
|
Successful |
Ppp5ctm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Creatine kinase
|
HOM
|
8f:6m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.215
|
Successful |
Ppp5ctm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Total cholesterol
|
HOM
|
4f:m
|
Linear Mixed Model framework, LME, including Weight
|
0.629
|
Successful |
Ppp5ctm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Total cholesterol
|
HOM
|
3f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.722
|
Successful |
Ppp5ctm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Alpha-amylase
|
HOM
|
4f:m
|
Linear Mixed Model framework, LME, including Weight
|
0.110
|
Successful |
Ppp5ctm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Alpha-amylase
|
HOM
|
3f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.951
|
Successful |
Ppp5ctm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Uric acid
|
HOM
|
8f:6m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.558
|
Successful |
Ppp5ctm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Total bilirubin
|
HOM
|
8f:6m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.422
|
Successful |
Ppp5ctm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Alkaline phosphatase
|
HOM
|
3f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.569
|
Successful |
Ppp5ctm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Alkaline phosphatase
|
HOM
|
4f:m
|
Linear Mixed Model framework, LME, including Weight
|
0.913
|
Successful |
Ppp5ctm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / HDL-cholesterol
|
HOM
|
8f:6m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.00318
|
Successful |
Ppp5ctm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Alanine aminotransferase
|
HOM
|
4f:m
|
Linear Mixed Model framework, LME, including Weight
|
0.608
|
Successful |
Ppp5ctm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Alanine aminotransferase
|
HOM
|
3f:7m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.690
|
Successful |
Ppp5ctm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / LDL-cholesterol
|
HOM
|
8f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.164
|
Successful |
Ppp5ctm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Aspartate aminotransferase
|
HOM
|
3f:7m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.568
|
Successful |
Ppp5ctm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Aspartate aminotransferase
|
HOM
|
4f:m
|
Linear Mixed Model framework, LME, including Weight
|
0.692
|
Successful |
Ppp5ctm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Lactate dehydrogenase
|
HOM
|
4f:m
|
Linear Mixed Model framework, LME, including Weight
|
0.359
|
Successful |
Ppp5ctm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Lactate dehydrogenase
|
HOM
|
3f:7m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.984
|
Successful |
Ppp5ctm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Iron
|
HOM
|
3f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.00580
|
Successful |
Ppp5ctm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Iron
|
HOM
|
4f:m
|
Linear Mixed Model framework, LME, including Weight
|
0.713
|
Successful |
Ppp5ctm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Free fatty acid
|
HOM
|
3f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.0375
|
Successful |
Ppp5ctm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Free fatty acid
|
HOM
|
4f:m
|
Linear Mixed Model framework, LME, not including Weight
|
0.847
|
Successful |
Ppp5ctm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Triglyceride
|
HOM
|
3f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.381
|
Successful |
Ppp5ctm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Triglyceride
|
HOM
|
4f:m
|
Linear Mixed Model framework, LME, including Weight
|
0.724
|
Successful |
Ppp5ctm1a(EUCOMM)Wtsi
|
WTSI
|
Dexa-scan analysis / Fat Mass
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0199
|
Successful |
Ppp5ctm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Chloride
|
HOM
|
8f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0178
|
Successful |
Ppp5ctm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Magnesium
|
HOM
|
4f:m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.224
|
Successful |
Ppp5ctm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Magnesium
|
HOM
|
3f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.840
|
Successful |
Ppp5ctm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Total protein
|
HOM
|
8f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.719
|
Successful |
Ppp5ctm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Albumin
|
HOM
|
8f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.173
|
Successful |
Ppp5ctm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Calcium
|
HOM
|
8f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0338
|
Successful |
Ppp5ctm1a(EUCOMM)Wtsi
|
WTSI
|
Calorimetry / Cumulative food intake
|
HOM
|
114f:237m
|
|
|
NotProcessed |
Ppp5ctm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Fructosamine
|
HOM
|
f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0813
|
Successful |
Ppp5ctm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Fructosamine
|
HOM
|
4f:m
|
Linear Mixed Model framework, LME, not including Weight
|
0.232
|
Successful |
Ppp5ctm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Phosphorus
|
HOM
|
8f:6m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.548
|
Successful |
Ppp5ctm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Iron
|
HOM
|
8f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.00763
|
Successful |
Ppp5ctm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Lactate dehydrogenase
|
HOM
|
8f:6m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.687
|
Successful |
Ppp5ctm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Aspartate aminotransferase
|
HOM
|
8f:6m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.162
|
Successful |
Ppp5ctm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / LDL-cholesterol
|
HOM
|
4f:m
|
Linear Mixed Model framework, LME, including Weight
|
0.523
|
Successful |
Ppp5ctm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / LDL-cholesterol
|
HOM
|
3f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.542
|
Successful |
Ppp5ctm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / HDL-cholesterol
|
HOM
|
4f:m
|
Linear Mixed Model framework, LME, including Weight
|
0.569
|
Successful |
Ppp5ctm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / HDL-cholesterol
|
HOM
|
3f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.759
|
Successful |
Ppp5ctm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Alanine aminotransferase
|
HOM
|
8f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.986
|
Successful |
Ppp5ctm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Total bilirubin
|
HOM
|
4f:m
|
Linear Mixed Model framework, LME, not including Weight
|
0.000937
|
Successful |
Ppp5ctm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Total bilirubin
|
HOM
|
3f:7m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.709
|
Successful |
Ppp5ctm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Alkaline phosphatase
|
HOM
|
8f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.538
|
Successful |
Ppp5ctm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Uric acid
|
HOM
|
4f:m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.373
|
Successful |
Ppp5ctm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Uric acid
|
HOM
|
3f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.606
|
Successful |
Ppp5ctm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Alpha-amylase
|
HOM
|
8f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.439
|
Successful |
Ppp5ctm1a(EUCOMM)Wtsi
|
WTSI
|
Dysmorphology / Body fat distribution
|
HOM
|
7f:7m
|
|
|
NotProcessed |
Ppp5ctm1a(EUCOMM)Wtsi
|
WTSI
|
Indirect Calorimetry / Cumulative food intake
|
HOM
|
284f:310m
|
|
|
NotProcessed |
Ppp5ctm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Glycerol
|
HOM
|
4f:m
|
Linear Mixed Model framework, LME, not including Weight
|
0.140
|
Successful |
Ppp5ctm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Glycerol
|
HOM
|
3f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.578
|
Successful |